NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations – HealthNewsReview.org
HealthNewsReview.org |
NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations
HealthNewsReview.org This news release describes “encouraging” results of a small 5-year trial to evaluate the safety and efficacy of stem cell transplants for aggressive cases of the most common form of multiple sclerosis, called relapsing-remitting MS. Known as HALT-MS … |